Västerås Central Hospital in Västerås is the county hospital of Västmanland County in Sweden. It has about 3,000 employees.

During the past decade, Centrallasarettet, Vasteras conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrallasarettet, Vasteras" #1 sponsor was "Advanz Pharma" with 2 trials, followed by "Anergis" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Anna Martling" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrallasarettet, Vasteras" #1 collaborator was "Astellas Pharma US, Inc." with 2 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "Nordic Cancer Union" with 1 trials as a collaborator, "Skane University Hospital" with 1 trials as a collaborator and "Swedish Cancer Foundation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Centrallasarettet, Vasteras" are "Atrial Fibrillation" (2 trials), "Colorectal Cancer" (2 trials), "Alcohol Abuse" (1 trials), "Allergic Rhinitis" (1 trials) and "Atrial Flutter" (1 trials). Many other conditions were trialed in "Centrallasarettet, Vasteras" in a lesser frequency.

Most popular intervention types in "Centrallasarettet, Vasteras" are "Drug" (10 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (3 trials), "Placebo" (2 trials), "Vernakalant Injection 20 mg/mL" (2 trials), "Acetylsalicylic acid" (1 trials) and "AllerT full dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrallasarettet, Vasteras" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centrallasarettet, Vasteras". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Centrallasarettet, Vasteras, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centrallasarettet, Vasteras, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".